Teva Animal Health in Missouri produces proprietary and generic veterinary products for the US market.
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA; TASE: TEVA) unit, Teva Animal Health Ltd., will resume the manufacture and distribution of non sterile liquid products at its St. Joseph, Missouri, plant, after receiving approval to do so from the US Food and Drug Administration (FDA).
Teva Animal produces proprietary and generic veterinary products, which are marketed in the US under the DVM Pharmaceuticals brand. The company thoroughly renovated and upgraded its plant to bring it to cGMP manufacturing capabilities.
Teva Animal Health president and CEO Dave Cunningham said, "We are pleased to receive this news from FDA. I am extremely proud of the hard work and dedication of our employees as we have been working non-stop to resume operations at this facility and this is the next step to that end."
Published by Globes [online], Israel business news - www.globes-online.com - on February 7, 2012
© Copyright of Globes Publisher Itonut (1983) Ltd. 2012